The chemical class known as neurexin II activators encompasses a range of compounds that can potentially upregulate or enhance the activity of neurexin II, a protein that plays a crucial role in synaptic formation and maintenance in the nervous system. These activators are not a homogeneous group but rather a collection of diverse molecules that may impact neurexin II through various mechanisms. The term 'activator' in this context typically refers to substances that increase the expression, stability, or functional activity of neurexin II. The increase in expression could be due to the enhanced transcription of the neurexin II gene, stabilization of its mRNA, or by hindering the degradation pathways that would normally break down the neurexin II protein. Furthermore, some activators might bind directly to neurexin II, changing its conformation in a way that promotes its interaction with other synaptic proteins, such as neuroligins, thereby influencing synaptic plasticity and function.
Within this class, the molecules might act at the genetic level to promote gene expression, or they may function post-translationally to prevent protein degradation or facilitate proper protein folding and trafficking to the synapse. The changes brought about by these activators can affect the synaptic architecture by modulating the abundance of neurexin II at synaptic junctions. This modulation can influence the synapse's ability to adapt to changes, a fundamental process for synaptic signaling and plasticity. Neurexin II activators could potentially affect the presynaptic neuron's ability to release neurotransmitters in response to an action potential, which in turn might affect the overall synaptic transmission efficacy. Since neurexin II is implicated in the precise connection between neurons, the activators have a significant role in ensuring the integrity of these connections, potentially affecting the complex network of neuronal communication and the plasticity of neural circuits.
더보기
제품명 | CAS # | 카탈로그 번호 | 수량 | 가격 | 引用 | RATING |
---|---|---|---|---|---|---|
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
히스톤 아세틸화를 유도하여 뉴렉신 II 전사를 증가시켜 유전자 주위에 더 접근하기 쉬운 염색질 상태를 만들 수 있습니다. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
뉴렉신 II의 유전자 프로모터에서 메틸화를 감소시켜 전사를 강화함으로써 뉴렉신 II를 상향 조절할 수 있습니다. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
뉴렉신 II가 프로테아좀 표적인 경우, 프로테아좀 매개 분해를 억제하여 뉴렉신 II 수치를 간접적으로 높일 수 있습니다. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
유전자 전사를 조절하는 세포 내 신호 전달 경로에 영향을 주어 뉴렉신 II의 발현을 조절할 수 있습니다. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $62.00 $90.00 $299.00 $475.00 $1015.00 $2099.00 | 69 | |
뉴런 기능에 관여하는 세포 내 신호 경로를 조절하여 뉴렉신 II 발현에 영향을 줄 수 있습니다. | ||||||
Eicosa-5Z,8Z,11Z,14Z,17Z-pentaenoic Acid (20:5, n-3) | 10417-94-4 | sc-200766 sc-200766A | 100 mg 1 g | $102.00 $423.00 | ||
막 유동성 및 관련 신호 경로의 변화를 통해 뉴렉신 II 발현에 잠재적으로 영향을 미칠 수 있습니다. | ||||||
Docosa-4Z,7Z,10Z,13Z,16Z,19Z-hexaenoic Acid (22:6, n-3) | 6217-54-5 | sc-200768 sc-200768A sc-200768B sc-200768C sc-200768D | 100 mg 1 g 10 g 50 g 100 g | $92.00 $206.00 $1744.00 $7864.00 $16330.00 | 11 | |
뉴런 막 구성과 세포 신호 전달을 변화시켜 뉴렉신 II 발현에 영향을 줄 수 있습니다. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
신경세포 분화 중 유전자 발현 조절 역할의 일부로서 뉴렉신 II 발현을 조절할 수 있습니다. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
유전자 발현 조절에 관여하는 단백질 키나아제 C의 활성화를 통해 뉴렉신 II를 상향 조절할 수 있습니다. |